No Data
Express News | Hang Seng Yinhua CSI Innovative Drugs Industry ETF (159316) “sucked” 0.33 billion yuan last week. The latest scale was nearly 1.6 billion yuan, a record high
ETF Market Review | AI computing power continues to be strong, the communications ETF rises by 4%, while Hong Kong's innovative pharmaceuticals experience a pullback, with the Hong Kong innovative pharmaceuticals ETF fund declining by 3%.
Gelonghui, August 19 | All three major indices of the A-share market closed lower. By the end of trading, the Shanghai Composite Index fell by 0.02%, the Shenzhen Component Index dropped by 0.12%, and the ChiNext Index decreased by 0.17%. The Beijing Stock Exchange 50 Index rose by 1.27%, reaching a new high. The market has seen over 20 trillion yuan in transaction volume for the fifth consecutive day, with total trading volume in the Shanghai, Shenzhen, and Beijing markets amounting to 26,407 billion yuan, a decrease of 1,685 billion yuan from the previous day. Over 2,900 individual stocks in the market rose. The concepts of CPO and consumer electronics continue to be hot, with Industrial Fulian reaching its daily limit and approaching a market capitalization of 1 trillion yuan. The liquor and robotics sectors showed active performance; however, large financial institutions generally took a breather, alongside the concepts of PEEK materials, lithography machines, and military information technology.
Express News | The Hang Seng Innovation Pharmaceutical ETF (159316) has attracted significant inflows for four consecutive trading days, setting new record highs in its asset size.
The Shanghai Composite Index rose above 3666 points, aiming for a seventh consecutive day of gains! The Innovative Medicine ETF (517380) by Tianhong has seen strong inflows for 12 consecutive days, while the Aerospace and Defense ETF (159241) by Tianhong
Gelonghui, August 12th | Buoyed by the continued extension of tariffs between China and the U.S., the Shanghai Composite Index closed up 0.51% at 3,666.33 points at midday, aiming for a seventh consecutive day of gains and continuing to set new highs for the year. The innovative pharmaceuticals and aerospace defense sectors saw the most significant pullbacks, with the Tianhong Innovative Pharmaceuticals ETF (517380) down 0.78% and the Tianhong Aerospace Defense ETF (159241) down 2.1%. Despite these declines, these two ETFs saw substantial buying interest, with the Tianhong Innovative Pharmaceuticals ETF (517380) receiving net subscriptions for 12 consecutive days, totaling RMB 187 million.
Express News | The Index closed in positive territory, with the new compilation methodology taking effect today. The Yinhua CSI Innovative Drugs Industry ETF (159316) saw a net subscription of 10 million units for the day.
Express News | The purity of innovative drugs is fully maximized, with the Yinhua CSI Innovative Drugs Industry ETF (159316) symbol Index undergoing a comprehensive upgrade.